En-Bo Cai (Enbo Cai)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Signaling Pathway

Top Venues

Molecules (Basel, Switzerland)

Phytotherapy research : PTR

Journal of agricultural and food chemistry

Biomedical chromatography : BMC

This page only lists publications with an associated author ORCID identifier.

Publications

Chi Liu, Xinyue Liu, Qing Ma, Fengyan Su, En-Bo Cai
Design, Synthesis, and Antitumor Activity of Isoliquiritigenin Amino Acid Ester Derivatives. Molecules (Basel, Switzerland) 29 (11) (2024)
Chi Liu, Xinyue Liu, Qing Ma, Fengyan Su, En-Bo Cai
Design, Synthesis, and Antitumor Activity of Isoliquiritigenin Amino Acid Ester Derivatives. Molecules (Basel, Switzerland) 29 (11) (2024)
Jing-Jing Xing, Xiao-Jie Mi, Jin-Gang Hou, En-Bo Cai, Si-Wen Zheng, Shi-Han Wang, Zi Wang, Chen Chen, Wei Li
Maltol mitigates cisplatin-evoked cardiotoxicity via inhibiting the PI3K/Akt signaling pathway in rodents in vivo and in vitro. Phytotherapy research : PTR 36 (4) (2022)
Jiahong Han, Xuan Fei, Nian Sun, Junjia Xing, En-Bo Cai, Limin Yang
Effect of Ligustri Lucidi Fructus on myelosuppression in mice induced by cytoxan. Biomedical chromatography : BMC (2022)
Jiahong Han, Yu Wang, En-Bo Cai, Lianxue Zhang, Yan Zhao, Nian Sun, Xiaoman Zheng, Siqi Wang
Study of the Effects and Mechanisms of Ginsenoside Compound K on Myelosuppression. Journal of agricultural and food chemistry 67 (5) (2019)